DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zg5vl9/global_acute) has announced the addition of the "Global Acute Myeloid Leukaemia Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Acute Myeloid Leukaemia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Acute Myeloid Leukaemia market. It covers active Acute Myeloid Leukaemia pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Topics Covered:
1. Acute Myeloid Leukaemia - Disease Overview
2. Acute Myeloid Leukaemia Pipeline Overview
3. Acute Myeloid Leukaemia Phase 3 Clinical Trial Pipeline Insights
4. Acute Myeloid Leukaemia Phase 2 Clinical Trial Pipeline Insights
5. Acute Myeloid Leukaemia Phase 1 Clinical Trial Pipeline Insights
6. Acute Myeloid Leukaemia Preclinical Research Pipeline Insights
7. Acute Myeloid Leukaemia Discovery Stage Pipeline Insights
8. Acute Myeloid Leukaemia Drug Development Activities - Geographic Landscape
8.1. Acute Myeloid Leukaemia R&D Activities in North America
8.2. Acute Myeloid Leukaemia R&D Activities in Europe
9. Acute Myeloid Leukaemia Pipeline - Licensing Activities
Table 1. Acute Myeloid Leukaemia Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Acute Myeloid Leukaemia Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Acute Myeloid Leukaemia Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Acute Myeloid Leukaemia Pipeline Molecules - Preclinical Research
Table 5. Acute Myeloid Leukaemia Pipeline Molecules - Drug Discovery
Table 6. Acute Myeloid Leukaemia R&D Activities by Geography
Table 7. Acute Myeloid Leukaemia Pipeline Molecules - North America
Table 8. Acute Myeloid Leukaemia Pipeline Molecules - Europe
Table 9. Acute Myeloid Leukaemia Pipeline - Licensing Activities
Figure 1. Acute Myeloid Leukaemia Pipeline Molecules by R&D Stage
Figure 2. Acute Myeloid Leukaemia R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/zg5vl9/global_acute